Gain Therapeutics (GANX) Non-Current Debt (2020 - 2026)
Gain Therapeutics (GANX) reported Non-Current Debt of $220,058 for Q2 2026, down 32.4% from $325,359 a year earlier and down 19.5% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Non-Current Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics posted Non-Current Debt of $300,084, down 8.6% from FY2024.
- Non-Current Debt has declined for five consecutive years, with a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $328,327 in FY2024 (-26.9%), $449,053 in FY2023 (-9.3%), $495,258 in FY2022 (-16.1%) and $590,468 in FY2021 (-17.5%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Debt in data going back to Q4 2020.
- Year over year, Non-Current Debt has now declined in each of the last 19 quarters, with an average decline of 18.6% over the last eight quarters.
- The year-over-year decline in Non-Current Debt has ranged between 8.6% (Q4 2025) and 32.4% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $273,265 (Q1 2026), $300,084 (Q4 2025) and $298,797 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Gain Therapeutics | 51.03 Mn | -8.26 Mn | - | 220,058.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220,058.00 |
| Mar 31, 2026 | 273,265.00 |
| Dec 31, 2025 | 300,084.00 |
| Sep 30, 2025 | 298,797.00 |
| Jun 30, 2025 | 325,359.00 |
| Mar 31, 2025 | 314,476.00 |
| Dec 31, 2024 | 328,327.00 |
| Sep 30, 2024 | 376,130.00 |
| Jun 30, 2024 | 375,352.00 |
| Mar 31, 2024 | 396,836.00 |
| Dec 31, 2023 | 449,053.00 |
| Sep 30, 2023 | 434,938.00 |
| Jun 30, 2023 | 466,638.00 |
| Mar 31, 2023 | 478,296.00 |
| Dec 31, 2022 | 495,258.00 |
| Sep 30, 2022 | 484,023.00 |
| Jun 30, 2022 | 542,263.00 |
| Mar 31, 2022 | 560,889.00 |
| Dec 31, 2021 | 590,468.00 |
| Sep 30, 2021 | 620,167.00 |
API Access
Gain Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();